依达拉奉治疗急性脑出血47例

Edaravone for Treating Acute Cerebral Hemorrhage in 47 Cases

目的探讨依达拉奉治疗急性脑出血的临床特点。方法选择2009年2月至2010年5月收治的急性脑出血患者94例,按照数字随机法均分为对照组和研究组,对照组采用常规治疗,研究组在常规治疗基础上加用依达拉奉,对两组患者的临床疗效及治疗前后的中国卒中量表(CSS)评分进行比较分析。结果与对照组相比,研究组基本痊愈率和总有效率均明显提高,无变化率和治疗后CSS评分均明显降低,两组差异均具有统计学意义(P<0.05)。结论依达拉奉对急性脑出血具有显著治疗效果,临床上值得推广。

Objective To probe the clinical effect of edaravone for treating acute cerebral hemorrhage.Methods Ninety-four patients with acute cerebral hemorrhage were selected in our hospital from February 2009 to May 2010 and were evenly divided into the control group and the study group according to the digital random method.The control group was treated by conventional treatment,while the study group was added the use of edaravone on this base of conventional treatment.The clinical efficacy and the CSS scores before and after treatment were compared between the two groups.Results Compared with control group,the basic recovery rate and total effective rate of the study group were increased significantly,whereas the non-change rate was significantly lower with statistical differences（P0.05）.At the same time,compared with control group,the neurological deficit scores after treatment in the study group were decreased and CSS scores were significantly lower with statistical differences（P0.05）.Conclusion Edaravone has significant treatment effect on acute cerebral hemorrhage,which should be worth being widely promoted in clinic.